Skip to content
KVUEKenvue

What Is KVUE Fair Value?

Kenvue (KVUE) fair value estimate using multiple valuation models, updated daily.

As of August 29, 2026, Kenvue (KVUE) has a composite fair value estimate of $22.46 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $19.17, suggesting the stock is undervalued by 17.2%.

Data as of August 29, 2026 (today)

Composite Fair Value

Undervalued4 of 4 models

$22.46

vs. current price of $19.17(+17.2%)

Undervalued$22.46Overvalued
$19.17

How Is KVUE Fair Value Calculated?

Four independent models estimate what KVUE is worth. Each uses different inputs and assumptions. The composite blends them by weight.

KVUE Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$30.26

+57.9%

Undervalued

Inputs used

FCF: 1.9BGrowth: 7.2%Discount: 6%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$26.80

+39.8%

Undervalued

Inputs used

Dividend: $0.84/yrReq. Return: 7%Growth: 3.6%

KVUE Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$12.09

-36.9%

Overvalued

Inputs used

EPS: $1.18Book Value: $5.50

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$11.83

-38.3%

Overvalued

Inputs used

EPS: $1.18Growth: 7.2%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$30.26Undervalued

Current price $19.17 is 57.9% below this estimate

CheapFair ValueExpensive
7.2%
0.0%30.0%
6.3%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$2.05B$1.92B
Year 2$2.19B$1.94B
Year 3$2.35B$1.96B
Year 4$2.52B$1.97B
Year 5$2.71B$1.99B
Year 6$2.90B$2.01B
Year 7$3.11B$2.03B
Year 8$3.34B$2.04B
Year 9$3.58B$2.06B
Year 10$3.84B$2.08B
Terminal Value$103.10B$55.88B

What Are KVUE's Key Financial Metrics?

Earnings & Growth

Current Price

$19.17

EPS (TTM)

$0.85

Forward P/E

15.4

Profit Margin

10.8%

Cash & Balance Sheet

Free Cash Flow

1.9B

EBITDA

3.5B

Book Value

$5.50

Total Debt

8.6B

What Do Analysts Say About KVUE?

Low

$18.00

Average

$19.50

High

$23.00

Upside

+1.7%

Current $19.17Avg Target $19.50Hold12 analysts

KVUE Fair Value FAQ

What is the fair value of KVUE?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), KVUE's estimated fair value is $22.46. The stock is currently trading at $19.17, which makes it undervalued by our analysis.

How is KVUE's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is KVUE overvalued or undervalued?

Based on our analysis, KVUE is undervalued. The current price of $19.17 is 17.2% below our estimated fair value of $22.46.

What do Wall Street analysts say about KVUE?

12 analysts cover Kenvue with a consensus rating of "Hold." The average price target is $19.50, ranging from $18.00 to $23.00. This implies 1.7% upside from the current price.